{"id":19039,"date":"2026-11-10T16:13:54","date_gmt":"2026-11-10T16:13:54","guid":{"rendered":"https:\/\/www.richterbiologics.eu\/choosing-a-cdmo-questions-that-will-lead-you-to-a-reliablepartner\/"},"modified":"2026-11-10T16:17:04","modified_gmt":"2026-11-10T16:17:04","slug":"choosing-a-cdmo-questions-that-will-lead-you-to-a-reliablepartner","status":"publish","type":"post","link":"https:\/\/www.richterbiologics.eu\/de\/choosing-a-cdmo-questions-that-will-lead-you-to-a-reliablepartner\/","title":{"rendered":"Choosing a CDMO: Questions That Will Lead You to a ReliablePartner"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Every biopharmaceutical company reaches the same crossroads when selecting a contract development and manufacturing (CDMO) partner. The temptation is to optimize for the lowest quote or the shortest lead time, or both. But the most consequential question is rarely asked directly: which partner will actually carry your program from early-phase clinical through commercial launch without a single avoidable disruption? […]<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\"Won't a large, global CDMO give us more security than a specialist?\"<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Company size can be reassuring, but it is not the same as reliability. Larger providers often spread capacity across a broad range of modalities and fairly large number of clients, which can mean your program competes for attention and expertise.<\/p>

Richter BioLogics offers something better: deep, focused specialization in microbial manufacturing. Your program, whether it\u2019s a protein, an antibody (VHH\/nanobody, ScFv-fragment, pDNA, or a vaccine, benefits from teams whose expertise is concentrated, and from an organization small enough to remain genuinely responsive while mature enough to withstand any regulatory scrutiny.<\/p>

Consistent quality outcomes require consistent people, processes, and leadership rather than reactive management. Our stability on all three fronts is a direct advantage to the programs we support.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\"What does a quality mindset actually change in daily operations?\"\n<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Quality in CDMO manufacturing is not simply a matter of passing audits. The real measure is whether that rigor is embedded in day-to-day work: in how deviations are investigated, how processes are validated, and how knowledge is preserved across teams.<\/p>

At Richter BioLogics, quality is an operating philosophy that runs through every function, and every client engagement. For your program, that means fewer surprises, more predictable timelines.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\"Why does a CDMO's regulatory record matter?\"\n<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Because a clean regulatory record signals several things about a prospective partner:<\/p>